These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28522101)

  • 1. Cardiovascular fitness in narcolepsy is inversely related to sleepiness and the number of cataplexy episodes.
    Matoulek M; Tuka V; Fialová M; Nevšímalová S; Šonka K
    Sleep Med; 2017 Jun; 34():7-12. PubMed ID: 28522101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy.
    Valko PO; Khatami R; Baumann CR; Bassetti CL
    J Neurol; 2008 Dec; 255(12):1900-3. PubMed ID: 18825431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD; Lai C; Weaver TE
    J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of REM sleep-related episodes in children with type 1 narcolepsy.
    Antelmi E; Pizza F; Vandi S; Neccia G; Ferri R; Bruni O; Filardi M; Cantalupo G; Liguori R; Plazzi G
    Brain; 2017 Jun; 140(6):1669-1679. PubMed ID: 28472332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brain PET study in patients with narcolepsy-cataplexy.
    Dauvilliers Y; Comte F; Bayard S; Carlander B; Zanca M; Touchon J
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):344-8. PubMed ID: 19850578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
    Poryazova R; Tartarotti S; Khatami R; Baumann CR; Valko P; Kallweit U; Werth E; Bassetti CL
    Eur Neurol; 2011; 65(3):175-82. PubMed ID: 21389728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study.
    Dauvilliers Y; Jaussent I; Lecendreux M; Scholz S; Bayard S; Cristol JP; Blain H; Dupuy AM
    Brain Behav Immun; 2014 Mar; 37():260-6. PubMed ID: 24394344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime performance deficits and physiological vigilance in untreated patients with narcolepsy-cataplexy compared to controls.
    Valley V; Broughton R
    Rev Electroencephalogr Neurophysiol Clin; 1981 Sep; 11(1):133-9. PubMed ID: 7313247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in narcolepsy.
    Daniels E; King MA; Smith IE; Shneerson JM
    J Sleep Res; 2001 Mar; 10(1):75-81. PubMed ID: 11285058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory evoked potentials compared to performance measures and EEG in assessing excessive daytime sleepiness in narcolepsy-cataplexy.
    Broughton R; Low R; Valley V; Da Costa B; Liddiard S
    Electroencephalogr Clin Neurophysiol; 1982 Nov; 54(5):579-82. PubMed ID: 6181981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a Therapeutic Drug for Narcolepsy].
    Irukayama-Tomobe Y; Yanagisawa M
    Brain Nerve; 2018 Nov; 70(11):1255-1263. PubMed ID: 30416119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NREM sleep alterations in narcolepsy/cataplexy.
    Ferri R; Miano S; Bruni O; Vankova J; Nevsimalova S; Vandi S; Montagna P; Ferini-Strambi L; Plazzi G
    Clin Neurophysiol; 2005 Nov; 116(11):2675-84. PubMed ID: 16221567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy.
    Bogan RK; Feldman N; Emsellem HA; Rosenberg R; Lu Y; Bream G; Khayrallah M; Lankford DA
    Sleep Med; 2015 Sep; 16(9):1102-8. PubMed ID: 26298786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
    Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
    Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.